Samsung Biologics Expands Global Manufacturing with GSK Facility Acquisition in Maryland Samsung Biologics announces the successful acquisition of GSK's Rockville facility, marking its first manufacturing site in the U.S. and enhancing global capacity.

Samsung Biologics Expands Global Manufacturing with GSK Facility Acquisition in Maryland #United_States #Rockville #Rockville,_Maryland #Samsung_Biologics #GSK

Samsung Biologics Honored for Sustainability at CDMO Leadership Awards 2026 Samsung Biologics has been awarded the Sustainability Leadership Award at the 2026 CDMO Leadership Awards, highlighting their commitment to sustainable practices.

Samsung Biologics Honored for Sustainability at CDMO Leadership Awards 2026 #Sustainability #South_Korea #Samsung_Biologics #Incheon #CDMO

Samsung Biologics and Eli Lilly to Launch Gateway Labs in South Korea for Biotech Innovation Samsung Biologics partners with Lilly to create a Gateway Labs site in Korea, promoting biotech innovation and research support for emerging companies.

Samsung Biologics and Eli Lilly to Launch Gateway Labs in South Korea for Biotech Innovation #South_Korea #Samsung_Biologics #Incheon #Biotech_Innovation #Lilly_Gateway_Labs

Samsung Biologics Achieves Independent Validation of Carbon Footprint System for Climate Accountability Samsung Biologics has bolstered its commitment to climate transparency by securing independent validation of its Product Carbon Footprint system, confirming adherence to global standards.

Samsung Biologics Achieves Independent Validation of Carbon Footprint System for Climate Accountability #Sustainability #South_Korea #Samsung_Biologics #Incheon #carbon_footprint

CEPI and Samsung Biologics Unite to Boost Vaccine Readiness for Future Epidemics CEPI and Samsung Biologics team up to enhance vaccine production capabilities against future pandemics, ensuring equitable access to protein-based vaccines.

CEPI and Samsung Biologics Unite to Boost Vaccine Readiness for Future Epidemics #Norway #Oslo #Samsung_Biologics #Vaccine_Production #CEPI

Samsung Biologics Achieves EcoVadis Platinum Rating for Sustainability Excellence Samsung Biologics has earned the prestigious EcoVadis Platinum sustainability rating, placing it among the top one percent of global companies recognized for CSR excellence.

Samsung Biologics Achieves EcoVadis Platinum Rating for Sustainability Excellence #Sustainability #South_Korea #EcoVadis #Samsung_Biologics #Incheon

Samsung Biologics Unveils Impressive Financial Results for FY 2025 Samsung Biologics reports strong financial performance in FY 2025, showcasing resilience and growth through strategic expansions and strong client demand.

Samsung Biologics Unveils Impressive Financial Results for FY 2025 #South_Korea #pharmaceutical #Samsung_Biologics #Incheon #CDMO

Samsung Biologics Boosts U.S. Manufacturing with Human Genome Sciences Acquisition Samsung Biologics has made a significant move by acquiring Human Genome Sciences from GSK, marking its entry into the U.S. manufacturing market.

Samsung Biologics Boosts U.S. Manufacturing with Human Genome Sciences Acquisition #United_States #Rockville #Samsung_Biologics #GSK #HGS

Samsung Biologics Achieves Top Rating for Water Security and Sustainability Efforts Samsung Biologics has been awarded an 'A' in Water Security by CDP, showcasing its commitment to environmental leadership and sustainability practices.

Samsung Biologics Achieves Top Rating for Water Security and Sustainability Efforts #South_Korea #Samsung_Biologics #Incheon #water_security #Environmental_Stewardship

Samsung Biologics Strengthens Focus as a Pure-Play CDMO Through Spin-Off Samsung Biologics has successfully completed its spin-off from Samsung Bioepis. This strategic move reinforces its position as a leading pure-play CDMO, enhancing its focus and market strength.

Samsung Biologics Strengthens Focus as a Pure-Play CDMO Through Spin-Off #South_Korea #Samsung_Biologics #Incheon #CDMO #Samsung_Bioepis

Samsung Biologics Reports Strong Financial Performance for Q3 2025 With New Initiatives Samsung Biologics has announced impressive financial results for Q3 2025, highlighting growth and new environmental initiatives aimed at enhancing client relationships.

Samsung Biologics Reports Strong Financial Performance for Q3 2025 With New Initiatives #South_Korea #Samsung_Biologics #Incheon #ExellenS #Plant_4

Samsung Biologics Unveils ExellenS™: A Game-Changer in Biomanufacturing Samsung Biologics introduces ExellenS™, a cutting-edge manufacturing framework designed for enhanced efficiency and quality in biomanufacturing, ensuring rapid tech transfers and predictable outcomes.

Samsung Biologics Unveils ExellenS™: A Game-Changer in Biomanufacturing #South_Korea #Samsung_Biologics #Incheon #Biomanufacturing #ExellenS™

Samsung Biologics Reports Strong Financial Growth in Second Quarter 2025 In its Q2 2025 report, Samsung Biologics showcases impressive financial results and strategic advancements in CDMO services, signalling robust growth and innovation.

Samsung Biologics Reports Strong Financial Growth in Second Quarter 2025 #South_Korea #earnings_report #Samsung_Biologics #Incheon #CDMO

Samsung Biologics Launches Innovative Drug Screening Services with Organoids Samsung Biologics introduces Samsung Organoids, advanced drug screening services to enhance drug discovery and development. Learn more!

Samsung Biologics Launches Innovative Drug Screening Services with Organoids #South_Korea #Samsung_Biologics #Incheon #Drug_Screening #Samsung_Organoids

Samsung Biologics Achieves Remarkable Growth in Q1 2025 Financial Results Samsung Biologics reports impressive financial results for Q1 2025, driven by operational efficiency and new partnerships, ensuring long-term growth.

Samsung Biologics Achieves Remarkable Growth in Q1 2025 Financial Results #South_Korea #Biopharmaceutical #Samsung_Biologics #Incheon #ADC_facility

Samsung Biologics Achieves Leadership in Water Security Management and Sustainability Efforts Samsung Biologics has been awarded 'Leadership' status and an A- rating for its effective water management practices, reflecting its commitment to sustainability.

Samsung Biologics Achieves Leadership in Water Security Management and Sustainability Efforts #Sustainability #South_Korea #Samsung_Biologics #Incheon #water_security

Samsung Biologics Reports Robust Financial Growth for 2024 Amid Expansions Samsung Biologics showcases impressive financial results for Q4 and FY 2024, highlighting its commitment to innovation and sustainability.

Samsung Biologics Reports Robust Financial Growth for 2024 Amid Expansions #South_Korea #Samsung_Biologics #Incheon #ADC_Services #Bio_Campus_II

Samsung Biologics Expands Operations and Services at J.P. Morgan Healthcare Conference 2025 At the J.P. Morgan Healthcare Conference 2025, Samsung Biologics outlines expansion plans and new service offerings, emphasizing growth in biologics.

Samsung Biologics Expands Operations and Services at J.P. Morgan Healthcare Conference 2025 #South_Korea #Samsung_Biologics #Incheon #ADC_Services #Bio_Campus_II

Samsung Biologics Enhances ADC Development with LigaChem Biosciences Collaboration Samsung Biologics announces the extension of its collaboration with LigaChem Biosciences to enhance antibody-drug conjugate (ADC) development services.

Samsung Biologics Enhances ADC Development with LigaChem Biosciences Collaboration #South_Korea #Samsung_Biologics #Incheon #LigaChem_Biosciences #ADC_Development

Samsung Biologics Earns Prestigious Spot in Dow Jones Sustainability Index for Fourth Year Samsung Biologics has been recognized in the Dow Jones Sustainability World Index, reflecting its unwavering commitment to sustainable practices.

Samsung Biologics Earns Prestigious Spot in Dow Jones Sustainability Index for Fourth Year #Sustainability #South_Korea #Dow_Jones #Samsung_Biologics #Incheon

Samsung Biologics Strengthens Decarbonization Efforts with Supplier ESG Day Samsung Biologics hosts its second Supplier ESG Day to encourage sustainable management practices among over 82 participating suppliers aiming for decarbonization.

Samsung Biologics Strengthens Decarbonization Efforts with Supplier ESG Day #Sustainability #South_Korea #Samsung_Biologics #ESG_Day #Incheon